Citation:Jorda M, Gomez-Fernandez C, Garcia M, Mousavi F, Walker G, Mejias A, et al 2009

From Cancer Guidelines Wiki

Citation


Jorda M, Gomez-Fernandez C, Garcia M, Mousavi F, Walker G, Mejias A, et al. P63 differentiates subtypes of nonsmall cell carcinomas of lung in cytologic samples: implications in treatment selection. Cancer 2009 Feb 25;117(1):46-50 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19347829.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Jorda M, Gomez-Fernandez C, Garcia M, Mousavi F, Walker G, Mejias A, et al 2009When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?Associate Professor Wendy Coopercompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Jorda_M,_Gomez-Fernandez_C,_Garcia_M,_Mousavi_F,_Walker_G,_Mejias_A,_et_al_2009&oldid=107065"